Company Quick10K Filing
American Bio Medica
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-12
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-25
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-30
8-K 2020-03-18 Other Events, Exhibits
8-K 2020-02-20 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-01-07 Officers
8-K 2019-11-14 Earnings, Exhibits
8-K 2019-08-14 Earnings, Other Events, Exhibits
8-K 2019-06-20 Shareholder Vote
8-K 2019-05-23
8-K 2019-05-20 Earnings, Exhibits
8-K 2019-04-16
8-K 2019-02-25 Enter Agreement
8-K 2018-12-20 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-06-21 Shareholder Vote
8-K 2018-03-02 Enter Agreement
8-K 2018-01-05 Officers

American Bio Medica Financials

ABMC Metrics, Comps, Filings

Quarterly | Annual

Business

For the transition period -------------- to -------------------

New York 14-1702188 (State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)   

122 Smith Road Kinderhook, New York 12106 (Address of principal executive offices) (Zip Code)


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarterly)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarterly)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Patriot Gold (PGOL) 4,463 0% 25.7 9% 1,935 226 436 0 166 166 4,261
Encision (ECIA) 3,709 51% -115.6 -4% 4,148 1,933 8,055 4,147 -152 -31 3,568
Innovus Pharmaceuticals (INNV) 5,796 65% -2.1 -63% 9,514 11,510 17,966 11,617 -5,984 -3,875 8,027
Blake Insomnia Therapeutics (BKIT) 3,681 -135.2 0 237 0 0 -27 -27 3,681
Geospatial (GSPH) 3,709 70% -6.3 -736% 111 3,656 273 190 -816 -586 3,668
Visium Technologies (VISM) 0 0.0 -31,116% 3 3,141 0 0 -796 -796 -3
Cartesian (CRTN) 3,632 30% -0.4 -44% 16,522 17,461 47,555 14,053 -7,270 -5,582 2,087
GraniteShares Platinum Trust (PLTM) 5,316 12.8 7% 5,803 2 0 0 415 415 5,316
Invesco CurrencyShares Singapore Dollar Trust (FXSG) 3,628 0% -50.4 1% 3,558 1 40 0 26 26 -1,288
Fieldpoint Petroleum (FPP) 3,628 0% 13.8 -5% 4,528 6,259 1,668 0 -241 247 3,414
American Church Mortgage (ACMC) 3,339 2.4 -0% 39,246 28,836 0 0 -48 1,343 3,218
Immune Pharmaceuticals (IMNP) 3,597 -0.9 -71% 20,716 19,874 0 0 -14,715 -13,953 12,494
American Bio Medica (ABMC) 3,580 35% -28.9 -20% 2,246 2,809 2,776 971 -440 -177 5,119
Empire Petroleum (EMPR) 3,576 0% -3.0 -30% 11,795 13,670 4,941 0 -3,541 -3,815 11,553
Genesis Financial (GFNL) 3,571 0% -1.1 -155% 2,427 3,394 10 0 -3,756 -3,242 3,551
Frontier Oilfield Services (FOSI) 3,542 0% -5.7 -319% 868 11,161 646 0 -2,768 -2,021 11,479
Sauer Energy (SENY) 3,496 49% -2.8 -116% 1,092 291 30 15 -1,271 -1,239 3,494
PowerVerde (PWVI) 3,175 0% -8.5 -707% 60 342 9 0 -427 -404 3,424
Puradyn Filter Technologies (PFTI) 3,451 24% -14.2 -47% 2,470 12,620 1,278 303 -1,160 -826 11,763
Invesco CurrencyShares Chinese Renminbi Trust (FXCH) 3,414 0% 1,654.7 -0% 3,419 1 4 0 -13 -13 -21,003

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2222936089155636465214474333524874332241589717822115613613815036927659113549915
Accounts Receivable1,0791,1388839401,2428109071,054952875909742782814648859802672789720721556611482521348421512546452392393492
Inventory3,2213,1763,2393,3133,0792,5712,4782,4812,1762,0711,9661,9291,8521,7221,8121,8241,8481,7461,6211,6101,5561,5821,5031,4501,4621,4731,3881,2611,2501,019973825890
PP&E1,3321,3411,3041,2761,2254,4631,1751,1901,1354,4781,0621,0409763,9179579429233,9308878668443,9308058238103,9747747547363,974699681663
Assets5,8895,8925,6365,6945,7204,7795,1585,2664,5254,9664,7434,3904,3384,0784,2514,4294,2163,7973,6383,5923,5493,3713,2783,1353,1432,8912,8772,7762,8082,4752,3162,1652,246
Accounts Payable6006846318771,0271,016698648762597633462510410423508429373470376305304304278306374430349459359521555606
Long-Term Debt1,5381,5181,4801,4531,4351,4045535231,2862,0672,0772,1472,2182,2722,1311,9771,7461,8181,8611,7641,8001,6811,6641,5271,6451,7461,7421,6461,5371,4911,554
Liabilities3,5083,5203,2663,5233,8043,4153,8964,2733,7293,6283,3623,0403,1403,1083,0253,2783,0592,8362,5132,4942,3712,3462,3732,2402,2872,2682,4992,5382,7462,6212,6832,5842,809
Stockholders' Equity2,3812,3722,3702,1711,9161,3641,2629937961,3381,3811,3501,1989701,2261,1511,1579611,1251,0981,1781,02590589585662337823872-146-367-419-563
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,4862,3652,3742,2962,2832,3022,1252,3802,2572,1322,0431,8111,7501,6811,5021,7681,5901,4571,4701,5051,4171,2171,3161,3061,3549391,0411,069878923958895
Cost of Revenue1,3351,3991,3771,3341,3921,8541,3391,4111,3511,2211,1661,0201,0271,010802919823919840796806678751741788638669632514617652536
Gross Profit1,151966997962891448786969906911877791723671700849767538630709611539565565566301372437364306306359
R&D5761535254456312431515246459245295145235455284846402623251920192023
SG&A9198809171,0791,0669051,0851,0658771,030769735755804724829679702667640643612586564535506553511476461441417
Tax154-50012-3414010002101201-21040020
Net Income123-28-15-206-264-565-424-294-2131459181-211-238-45-83-2-2031-44-88-215-132-71-49-293-267-147-202-240-56-144
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating160258-155361-743-26950718726-9-106177-861412517213056-47163-56-110-55292-149
Cash Investing-80-32-211-11-4624-1-11-10-43-2-5-7-7-3-30-24-9-42-6-7-8000
Cash Financing-80-15589-273666369-523-311-89568-4037-216-184-2317243-9736-119118101-4-111-4765